First Tracks Biotherapeutics Stock Price, News & Analysis
Company Description
First Tracks Biotherapeutics (NASDAQ: TRAX) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $549.6M, ranking #3,473 among all listed U.S. companies by market cap.
TRAX stock has declined 14.1% over the past year. Shares last traded at $15.97.
This page provides a comprehensive overview of TRAX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
First Tracks Biotherapeutics (TRAX) stock last traded at $15.97, down 4.76% from the previous close. Over the past 12 months, the stock has lost 14.1%. At a market capitalization of $549.6M, TRAX is classified as a small-cap stock with approximately 34.9M shares outstanding.
TRAX Rankings
Latest News
First Tracks Biotherapeutics has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include conferences, earnings. View all TRAX news →
SEC Filings
First Tracks Biotherapeutics has filed 5 recent SEC filings, including 2 Form 424B3, 1 Form 4, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRAX SEC filings →
Insider Radar
Insider selling at First Tracks Biotherapeutics over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Upcoming Events
Leerink one-on-one meetings
ANB033 celiac top-line data
ANB033 EoE top-line data
First Tracks Biotherapeutics has 3 upcoming scheduled events. The next event, "Leerink one-on-one meetings", is scheduled for July 14, 2026 (in 33 days). Investors can track these dates to stay informed about potential catalysts that may affect the TRAX stock price.
Short Interest History
Days to Cover History
TRAX Company Profile & Sector Positioning
First Tracks Biotherapeutics (TRAX) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ. In monthly performance, the stock ranks #3,810 among all tracked companies.